Histologic transformation (HT) to an aggressive lymphoma is a well-described event in the natural history and clinical course of patients with so-called indolent lymphomas. This phenomenon has been ...

Send comments and news tips to [email protected]. Cite this: Bendamustine and Rituximab Combo Shines in Indolent Lymphoma - Medscape - Jun 03, 2012.

Indolent ATL consists of smoldering and 'favorable' chronic-type, and aggressive ATL consists of acute, lymphoma and 'unfavorable' chronic-type.

An expert discusses that while the liso-cel trial did not show a statistically significant overall survival benefit—likely ...

Non-Hodgkin lymphoma Non-Hodgkin lymphoma is a broader category with many subtypes, each with its own set of characteristics. This type can be either aggressive or indolent, with treatments ...

These investigators used SEER data to compare the outcomes of transformed indolent non-Hodgkin lymphomas with de novo DLBCL at a population level, a situation for which little data exist.

Key Takeaways Breyanzi showed significant efficacy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma, achieving primary and secondary endpoints in the TRANSCEND FL trial. Marginal zone ...

SAN DIEGO — Treatment with axicabtagene ciloleucel conferred durable benefit to patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, according to study results presented at ...

Session ID: 2025-03-15:948912e6f597fce6f723012b Player Element ID: Vd3f00cad_3bde_41e8_a8cb_45d5e0b5f075_6366189537112 ...

Indolent CD4+ cytotoxic chimeric antigen receptor (CAR) T-cell lymphoma involving the small intestine was diagnosed in a patient who had previously received ciltacabtagene autoleucel (cilta-cel) CA ...

Abstract Histologic transformation (HT) to an aggressive lymphoma is a well-described event in the natural history and clinical course of patients with so-called indolent lymphomas. This phenomenon ...